These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16901594)

  • 1. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.
    Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian analysis of a physiologically based pharmacokinetic model for perchloroethylene in humans.
    Qiu J; Chien YC; Bruckner JV; Fisher JW
    J Toxicol Environ Health A; 2010; 73(1):74-91. PubMed ID: 19953421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of perchloroethene: dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L-cysteine in rats and humans after inhalation.
    Völkel W; Friedewald M; Lederer E; Pähler A; Parker J; Dekant W
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):20-7. PubMed ID: 9875296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of a harmonized physiologically based pharmacokinetic (PBPK) model for perchloroethylene toxicokinetics in mice, rats, and humans.
    Chiu WA; Ginsberg GL
    Toxicol Appl Pharmacol; 2011 Jun; 253(3):203-34. PubMed ID: 21466818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
    Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of trichloroacetic acid to liver tumors observed in perchloroethylene (perc)-exposed mice.
    Sweeney LM; Kirman CR; Gargas ML; Dugard PH
    Toxicology; 2009 Jun; 260(1-3):77-83. PubMed ID: 19464572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age.
    Allen BC; Hack CE; Clewell HJ
    Risk Anal; 2007 Aug; 27(4):947-59. PubMed ID: 17958503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.
    Marino DJ; Clewell HJ; Gentry PR; Covington TR; Hack CE; David RM; Morgott DA
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):44-54. PubMed ID: 16442684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of physiologically based pharmacokinetic models in risk assessment: an example with perchloroethylene.
    Clewell HJ; Gentry PR; Kester JE; Andersen ME
    Crit Rev Toxicol; 2005 Jun; 35(5):413-33. PubMed ID: 16097137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform.
    Liao KH; Tan YM; Conolly RB; Borghoff SJ; Gargas ML; Andersen ME; Clewell HJ
    Risk Anal; 2007 Dec; 27(6):1535-51. PubMed ID: 18093051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute perchloroethylene exposure alters rat visual-evoked potentials in relation to brain concentrations.
    Boyes WK; Bercegeay M; Oshiro WM; Krantz QT; Kenyon EM; Bushnell PJ; Benignus VA
    Toxicol Sci; 2009 Mar; 108(1):159-72. PubMed ID: 19098276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model.
    Byczkowski JZ; Kinkead ER; Leahy HF; Randall GM; Fisher JW
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):228-36. PubMed ID: 8171430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.
    Hack CE; Chiu WA; Jay Zhao Q; Clewell HJ
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):63-83. PubMed ID: 16889879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics.
    Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
    J Toxicol Environ Health; 1995 Mar; 44(3):301-17. PubMed ID: 7897693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicokinetics of inhaled trichloroethylene and tetrachloroethylene in humans at 1 ppm: empirical results and comparisons with previous studies.
    Chiu WA; Micallef S; Monster AC; Bois FY
    Toxicol Sci; 2007 Jan; 95(1):23-36. PubMed ID: 17032701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations.
    David RM; Clewell HJ; Gentry PR; Covington TR; Morgott DA; Marino DJ
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):55-65. PubMed ID: 16439044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone.
    Mörk AK; Jonsson F; Johanson G
    Toxicol Appl Pharmacol; 2009 Nov; 240(3):423-32. PubMed ID: 19660484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
    Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
    Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
    Liao KH; Tan YM; Clewell HJ
    Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.